FISCHER35.20

Fischer Medical Ventures Limited

· Pharma & Health
₹ CrorePeersTARSONSLAXMIDENTLFABTECHGKBMcap ₹2,304 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
FISCHER
FY26
TARSONS
FY26
LAXMIDENTL
FY26
FABTECH
FY26
Peer
Median
Valuation — at last close
P/E73.33×118.59×36.76×14.71×36.76× +99%
P/B5.99×2.67×4.58×1.56×2.67× +124%
EV/EBITDA54.88×17.44×25.26×17.14×17.44× +215%
Market Cap₹2,304 Cr₹1,697 Cr₹1,117 Cr₹654 Cr₹1,117 Cr +106%
Growth
Revenue YoY (latest Q)249.42%20.66%13.87%10.26%13.87% +1698%
Net Income YoY (latest Q)-24.30%-180.99%23.83%168.73%23.83% -202%
Profitability
EBITDA Margin13.96%27.91%15.62%8.52%15.62% -11%
Net Income Margin10.05%3.39%10.41%9.34%9.34% +8%
Return on Common Equity8.05%2.26%11.87%9.14%9.14% -12%
Return on Capital Employed9.71%2.32%10.46%6.65%6.65% +46%
Return on Assets4.62%1.21%9.84%5.87%5.87% -21%
Credit & Quality
Total Debt/Equity0.19×0.60×0.00×0.10×0.10× +90%
Interest Coverage6.87×0.95×20.15×7.14×7.14× -4%
Scale — latest FY
Revenue / Total Income₹309 Cr₹423 Cr₹278 Cr₹411 Cr₹411 Cr -25%
Net Income₹31 Cr₹14.3 Cr₹28.9 Cr₹38.4 Cr₹28.9 Cr +7%
Total Assets₹671 Cr₹1,186 Cr₹294 Cr₹654 Cr₹654 Cr +3%
EPS₹0.48₹2.69₹5.53₹10₹5.53 -91%
Book Value per Share₹5.88₹119.29₹44.42₹94.43₹94.43 -94%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.